October 22, 2016 12:16 AM ET


Company Overview of Amplimmune, Inc.

Company Overview

Amplimmune, Inc. develops immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation, and infectious diseases. The company’s biologics are co-stimulatory/co-inhibitory molecules that rebalance the immune system. Its products include AMP-110, a therapeutic candidate that targets T-cells and elicits a coinhibitory signal, which suppresses T-cell responses for the treatment of autoimmune/inflammatory disorders and transplantation; and AMP-224, a fusion protein that blocks the interaction between PD-1 and B7-H1 for treatment of cancer and chronic infections. Amplimmune, Inc. has a strategic alliance and partnership with GlaxoSmithKline. The company was incorpo...

45 West Watkins Mill Road

Gaithersburg, MD 20878

United States

Founded in 2006





Key Executives for Amplimmune, Inc.

Scientific Founder and Board Observer
Scientific Founder
Scientific Founder and Board Observer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Amplimmune, Inc., please visit www.amplimmune.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.